AdultVag candidiasis/candidal balanitis 150 mg single dose. Dermal infections including tinea pedis, corporis, cruris & candida infections 150 mg once wkly for 2-4 wk. Tinea pedis Up to 6 wk. Tinea versicolor 300 mg once wkly for 2 wk, 3rd wkly dose: 300 mg may be needed or 300-400 mg single dose.
Hypersensitivity. Discontinue use if clinical signs or symptoms of liver disease develops. Exfoliative cutaneous reactions eg, SJS, TEN; AIDS, cancer, haematological abnormalities; congenital or documented acquired QT prolongation, cardiomyopathy, sinus bradycardia, existing symptomatic arrhythmias, electrolyte disturbances eg, hypokalaemia, hypomagnesaemia, hypocalaemia. Concomitant use w/ medications not metabolized by CY34A but prolonging QT interval. Hepatic & renal dysfunction. Women of childbearing potential should use effective contraception during & approx 1 wk after last dose. Avoid use during pregnancy. Not recommended during lactation. Not recommended in childn <16 yr.
Sign Out
